SUTRO BIOPHARMA INC (STRO:NASDAQ)
$28.25 -0.98 (-3.3527%)
Analysed SUTRO BIOPHARMA INC (STRO:NASDAQ) News Sources
Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now
29-04-2026
yahoo.com
Meta downgraded, Qualcomm upgraded: Wall Street's top analyst calls
30-04-2026
yahoo.com
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program
01-05-2026
yahoo.com
Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates
05-05-2026
yahoo.com
MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates
06-05-2026
yahoo.com
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
14-05-2026
yahoo.com
US$47.10 - That's What Analysts Think Sutro Biopharma, Inc. (NASDAQ:STRO) Is Worth After These Results
17-05-2026
yahoo.com
News Flash: Analysts Just Made A Massive Upgrade To Their Sutro Biopharma, Inc. (NASDAQ:STRO) Forecasts
28-05-2026
yahoo.com
Barclays initiates oncology-focused biotechs with positive outlook
28-05-2026
yahoo.com
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million
31-05-2026
fool.com
What is the current price of SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The current price of SUTRO BIOPHARMA INC (STRO:NASDAQ) is $28.25.
SUTRO BIOPHARMA INC (STRO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUTRO BIOPHARMA INC (STRO:NASDAQ) since the previous trading day is $-0.98.
SUTRO BIOPHARMA INC (STRO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUTRO BIOPHARMA INC (STRO:NASDAQ) since the previous trading day is -3.3527%.
What is the most recent average sentiment score for SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The most recent average sentiment score for SUTRO BIOPHARMA INC (STRO:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The most recent sentiment for SUTRO BIOPHARMA INC (STRO:NASDAQ) is .
SEC-8K** Filing Available For SUTRO BIOPHARMA INC (STRO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.